PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 93 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $428,000 | +3.4% | 166,750 | +0.7% | 0.00% | – |
Q4 2020 | $414,000 | +22.1% | 165,551 | +1.1% | 0.00% | – |
Q3 2020 | $339,000 | -33.3% | 163,749 | -0.0% | 0.00% | – |
Q2 2020 | $508,000 | +28.9% | 163,790 | -5.3% | 0.00% | – |
Q1 2020 | $394,000 | -72.9% | 172,866 | -56.9% | 0.00% | -100.0% |
Q4 2019 | $1,453,000 | +19.3% | 401,306 | +12.4% | 0.00% | – |
Q3 2019 | $1,218,000 | -59.5% | 357,106 | -44.3% | 0.00% | -100.0% |
Q2 2019 | $3,011,000 | – | 640,648 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 778,230 | $5,308,000 | 5.22% |
BVF INC/IL | 3,592,549 | $24,501,000 | 2.48% |
Prosight Management, LP | 563,763 | $3,845,000 | 2.41% |
SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $5,456,000 | 0.83% |
Virtus ETF Advisers LLC | 125,695 | $857,000 | 0.74% |
EAM Investors, LLC | 521,460 | $3,556,000 | 0.59% |
Tekla Capital Management LLC | 2,087,380 | $14,236,000 | 0.55% |
Orbimed Advisors | 5,550,000 | $37,851,000 | 0.47% |
EAM Global Investors LLC | 125,635 | $857,000 | 0.44% |
Schonfeld Strategic Advisors LLC | 830,637 | $5,665,000 | 0.42% |